| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Imaging |
1 From the Department of Diagnostic Radiology, the University of Texas M. D. Anderson Cancer Center, Box 57, 1515 Holcombe Blvd, Houston, TX 77030. Received January 7, 1998; revision requested March 6; final revision received November 23; accepted March 8, 1999. Address reprint requests to E.M.L. (e-mail: eloyer@di.mdacc.tmc.edu).
PURPOSE: To define the hemodynamic features of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma by using quadruple phase helical computed tomography (CT) and determine the value of this information in characterizing tumors.
MATERIALS AND METHODS: Helical CT of the liver was performed in 45 patients with newly diagnosed HCC or peripheral cholangiocarcinoma. Scans were obtained before and 25 seconds, 70 seconds, and 2–6 minutes after the start of the contrast material injection. The intensity and spatial distribution of contrast material uptake were evaluated during all phases. Time-attenuation curves were established for each lesion. Relative attenuation and lesion conspicuity were assessed. A diagnostic confidence level was assigned to each lesion.
RESULTS: In the majority of HCC lesions, a single, early peak of enhancement followed by a continuous decrease in tumor attenuation over time was seen. The greatest tumor conspicuity occurred during the delayed phase. In cholangiocarcinoma, tumor attenuation increased during the delayed phase. In the majority of lesions, the greatest tumor conspicuity was seen during the portal venous phase. In both tumor types, the diagnostic confidence level improved when the delayed phase was used.
CONCLUSION: The variation over time in the intensity of contrast enhancement in HCC and cholangiocarcinoma differs sufficiently to make this a useful diagnostic criterion. The delayed phase is particularly important because it amplifies this difference.
Index terms: Bile ducts, neoplasms, 76.321 • Computed tomography (CT), contrast enhancement, 76.12113, 76.12114 • Computed tomography (CT), helical, 76.12115 • Liver, CT, 76.12111, 76.12113, 76.12114, 76.12115 • Liver neoplasms, 76.321, 76.323
This article has been cited by other articles:
|
|
 |
|
  T. Uenishi, O. Yamazaki, H. Tanaka, S. Takemura, T. Yamamoto, S. Tanaka, S. Nishiguchi, and S. Kubo Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma Ann. Surg. Oncol., February 1, 2008; 15(2): 583 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Kim, J. M. Lee, J. K. Han, K. H. Kim, J. Y. Lee, and B. I. Choi Peripheral Mass Forming Cholangiocarcinoma in Cirrhotic Liver Am. J. Roentgenol., December 1, 2007; 189(6): 1428 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-X. Xu, M.-D. Lu, G.-J. Liu, X.-Y. Xie, Z.-F. Xu, Y.-L. Zheng, and J.-Y. Liang Imaging of Peripheral Cholangiocarcinoma With Low-Mechanical Index Contrast-Enhanced Sonography and SonoVue: Initial Experience J. Ultrasound Med., January 1, 2006; 25(1): 23 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-C. Zeng, Z.-Y. Tang, J. Fan, J. Zhou, L.-X. Qin, S.-L. Ye, H.-C. Sun, B.-L. Wang, J.-Y. Zhang, Y. Yu, et al. Radiation Therapy for Adrenal Gland Metastases from Hepatocellular Carcinoma Jpn. J. Clin. Oncol., February 1, 2005; 35(2): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Choi, J. K. Han, S. T. Hong, and K. H. Lee Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis Clin. Microbiol. Rev., July 1, 2004; 17(3): 540 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Y. Lee, M. E. O'Malley, M. A. Haider, and A. Hanbidge Triple-Phase MDCT of Hepatocellular Carcinoma Am. J. Roentgenol., March 1, 2004; 182(3): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Hussain, I. Syed, H. V. Nghiem, T. D. Johnson, R. C. Carlos, W. J. Weadock, and I. R. Francis T2-weighted MR Imaging in the Assessment of Cirrhotic Liver Radiology, March 1, 2004; 230(3): 637 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Szklaruk, P. M. Silverman, and C. Charnsangavej Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma Am. J. Roentgenol., February 1, 2003; 180(2): 441 - 454. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Choi, E. M. Loyer, R. A. DuBrow, H. Kaur, C. L. David, S. Huang, S. Curley, and C. Charnsangavej Radio-frequency Ablation of Liver Tumors: Assessment of Therapeutic Response and Complications RadioGraphics, October 1, 2001; 21(90001): S41 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Lee, H. K. Lim, K. M. Jang, S. H. Kim, S. J. Lee, J. H. Lim, and I. W. Choo Radiologic Spectrum of Cholangiocarcinoma: Emphasis on Unusual Manifestations and Differential Diagnoses RadioGraphics, October 1, 2001; 21(90001): S97 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maetani, K. Itoh, C. Watanabe, T. Shibata, F. Ametani, H. Yamabe, and J. Konishi MR Imaging of Intrahepatic Cholangiocarcinoma with Pathologic Correlation Am. J. Roentgenol., June 1, 2001; 176(6): 1499 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Catalano and G. D. Dodd III Proper Terminology for Multiple-Phase Helical CT of the Liver Am. J. Roentgenol., February 1, 2001; 176(2): 547 - 548. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Lee, J. K. Han, T. K. Kim, Y. H. Kim, B. I. Choi, M. C. Han, K. S. Suh, and S. W. Kim CT Features of Intraductal Intrahepatic Cholangiocarcinoma Am. J. Roentgenol., September 1, 2000; 175(3): 721 - 725. [Abstract] [Full Text] [PDF]
|
|
